Get the Daily Brief
Latest Biotech News
Cancer screening test advances through FDA advisory gate
An FDA advisory panel voted to endorse Grail’s multi-cancer blood test, Galleri, concluding that the benefits outweigh the risks for adults meeting the proposed indication. The panel voted...
IgA nephropathy rivalry heats up with late-stage wins
Roche reported positive phase 3 results for sefaxersen in primary IgA nephropathy, supporting statistically significant and clinically meaningful improvements in proteinuria reduction versus...
CAR-T data recalibration amid autoimmune safety scrutiny
Kyverna’s long-term miv-cel readout is being read against a backdrop of safety issues across autoimmune CAR-T peer programs, where investors and regulators are increasingly demanding deeper...
AI-native drug discovery funding boosts clinical pipeline
Enveda Biosciences secured a $311 million Series E round to advance multiple AI-designed oral drug candidates through clinical development and scale its nature-derived discovery platform, PRISM....
Robot-assisted surgery governance update in China
China’s robotic surgery consensus for colorectal cancer was updated, with the Robotic Surgery Group of the Colorectal Cancer Committee of the Chinese Medical Doctor Association publishing its 2025...
Cell therapy platform collaboration for patient-matched pancreatic models
Genialis and Inventia Life Science announced a collaboration to connect patient biology to 3D pancreatic ductal adenocarcinoma models. Genialis will use its Supermodel to characterize patient...
AI at the bedside and diagnostics: bloodstream and imaging workflow advances
Recent reporting highlights expanding clinical adoption of AI workflows that connect image analysis, clinical context, and diagnostics decision-making. From new approaches that sharpen...
Med-tech innovation funding and regulatory momentum in interventional devices
Anaconda Biomed raised $56 million to support product development and clinical work for its stroke tech platform, including completion of the Athena pivotal study under an investigational device...
At-home screening startup raises Series A
Teal Health secured $22 million for an at-home HPV cervical cancer screening device, positioning the company to scale its product and clinical evidence generation. The Series A was led by .406...
FDA-adjacent progress for multi-cancer blood screening
An FDA advisory panel endorsed Grail’s multi-cancer early detection blood test, Galleri, concluding that benefits outweigh risks for adults meeting the proposed indication. The panel voted 10–0 on...
Clinical Phase 3 momentum in IgA nephropathy with Roche’s mRNA-targeting candidate
Roche reported positive Phase 3 results for sefaxersen in primary IgA nephropathy, moving the program closer to regulatory filing. The company’s update positions sefaxersen (licensed from Ionis...
Otsuka and Ionis chase another precision-ALS milestone in FUS-associated disease
Otsuka Pharmaceutical and Ionis Pharmaceuticals announced positive Phase 3 results in the Fusion study for ulefnersen in FUS-associated amyotrophic lateral sclerosis. The data included...
AI platform capital raises as clinical programs expand
Enveda secured a $311 million Series E to advance its AI-driven drug discovery platform and expand its clinical pipeline. The nature- and microbe-derived approach relies on AI for candidate...
AI drug design startup Basecamp lands large Series C for in-vivo cell therapies
Basecamp Research completed an oversubscribed $140 million Series C to train its next-generation EDEN foundation models and apply them to in-vivo cell therapy design. The company said its EDEN...
Genetic medicines: mutation-agnostic CRISPR therapy framework heads toward clinic
A “mutation-agnostic” CRISPR gene therapy approach aimed at scaling inherited rare-disease treatment is moving toward clinical use. Fyodor Urnov, director for therapeutic R&D at the Innovative...
M&A and portfolio reshaping in neurodegeneration and rare disease
Lexeo Therapeutics agreed to acquire Mantle Therapeutics, expanding its Friedreich’s ataxia (FA) portfolio and research collaborations. The deal includes Mantle programs across clinical,...
New device round: at-home HPV screening moves forward with Series A financing
Teal Health raised $22 million to advance an at-home HPV cervical cancer screening device in the clinic. The Series A round was led by .406 Ventures, with additional backing from Emerson...
Device sector funding: Anaconda raises $56 million for stroke catheter trial work
Anaconda Biomed SL raised $56 million for product development and clinical work, including completion of a pivotal investigational device exemption study evaluating its Ana Funnel catheter for...
Industry funding and strategy: Enveda’s and ecosystem competition widen for AI drug discovery
The AI-drug-discovery funding cycle intensified as Enveda’s Series E added to the momentum around “platform-to-clinic” strategies. Investors appear to be rewarding companies that can demonstrate...
Regulatory green light for multi-cancer blood screening
An FDA advisory panel voted in favor of Grail’s Galleri multi-cancer early detection blood test, concluding that benefits outweigh risks for adults meeting the proposed indication criteria. In the...